GILEAD SCIENCES, INC. (GILD) Options Risk Score
Real-time risk analysis for GILD options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full GILD options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan GILD Now — Free →
Is it risky to sell options on GILEAD SCIENCES, INC. (GILD) right now?
Over a 4-week expiry window, GILEAD SCIENCES, INC. (GILD) scores 100 out of 100 for options catalyst risk (HIGH). The contributing signals are an upcoming earnings report, 14 recent news items, 5 active legal filings and 15 clinical-trial catalysts within the 4-week window. A HIGH reading (70+) means GILD has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.
GILD shows an IV Rank of 77 — implied volatility is near the top of its own one-year range, so GILD options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 37%. IV Rank answers how GILD options are priced against their own history, which is the starting point for choosing between selling and buying premium.
The 2026-08-04 earnings report sits inside a standard monthly expiry for GILD, so implied volatility should stay bid into the date and drop sharply once it passes.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer